Gladstone NOW: The Campaign Join Us on the Journey✕
121 - 135 of 339 Results Clear All
12 Common Questions Answered by Gladstone’s Virologists
Gladstone Experts COVID-19
Unable to return to his home country during the COVID-19 surge in India, a Gladstone postdoc took to YouTube to share useful information about the virus and how to stay protected
Gladstone Experts Graduate Students and Postdocs COVID-19 Marson Lab
While the practice of placing papers on preprint servers ahead of peer review remains controversial in the scientific community worldwide, many Gladstone investigators are using bioRxiv to advance their research and get information out more quickly
Gladstone Experts COVID-19 Krogan Lab McDevitt Lab Ott Lab Pollard Lab
Steve Finkbeiner is leading key components of this unprecedented resource to boost ALS research.
Gladstone Experts ALS Center for Systems and Therapeutics Finkbeiner Lab AI Robotic Microscopy Stem Cells/iPSCs
Nature—Advances in artificial intelligence are enabling scientists to make discoveries from images of cells, by detecting features and patterns that are invisible to the human eye. Senior Investigator Steve Finkbeiner explains how his lab trained an algorithm to detect structures inside unlabeled cells, and differentiate live from dead cells.
Gladstone Experts Taube-Koret Center for Neurodegenerative Disease Research Finkbeiner Lab AI
Gladstone researchers harness unique tools and perspectives to study life-threatening seizures that lack a cure
Gladstone Experts Epilepsy Center for Neurovascular Brain Immunology Neurological Disease Akassoglou Lab Mucke Lab Palop Lab Paz Lab Deep Dive
The Mercury News—Director of Gladstone Institute of Virology Melanie Ott, MD, PhD, comments on the new coronavirus variants and says vaccines currently distributed in the US protect against hospitalization and death from COVID-19.
Gladstone Experts COVID-19 Virology Ott Lab
San Francisco Business Times—Melanie Ott, MD, PhD, director of the Gladstone Institute of Virology, is one of several key Bay Area women life scientists sharing their views on their careers, the pandemic, and the path ahead for women leaders.
Gladstone Experts COVID-19 Virology Ott Lab
San Francisco Public Press—Senior Investigator Warner Greene describes the efforts of Gladstone scientists to discover ways to treat the acute and long-term consequences of COVID-19, and their hope of discovering antiviral approaches that could be ready for use to battle future pandemic viruses.
Gladstone Experts COVID-19 Virology Greene Lab
Amber Freed is racing against the clock to cure her son from a rare neurological condition
Donor Stories Gladstone Experts Epilepsy Neurological Disease Paz Lab
ABC7 News—Gladstone President Deepak Srivastava, MD, a pediatric cardiologist, explains how his group discovered a potential new drug to treat a debilitating disease due to the hardening of heart valves.
Gladstone Experts Congenital Heart Disease Cardiovascular Disease Srivastava Lab Stem Cells/iPSCs
Nine tips for your next online conference
Postdoctoral and Graduate Student Education and Research Development Affairs Gladstone Experts Graduate Students and Postdocs
San Francisco Chronicle—The United States is trying accelerate coronavirus vaccine distribution, which could allow the country to achieve herd immunity. However, Gladstone virologist Warner Greene points out that the coronavirus is a global problem, and ending the pandemic will require mobilizing vaccines around the world.
Gladstone Experts COVID-19 Virology Greene Lab
San Francisco Chronicle—New coronavirus variants are emerging around the world, including in the Bay Area. Melanie Ott, director of the Gladstone Institute of Virology, explains that if the vaccine rollout isn’t fast enough, viral variants that can evade the vaccine may become prevalent, rendering the vaccine partially ineffective.
Gladstone Experts COVID-19 Virology Ott Lab
ABC7 News—Gladstone Institute of Virology Director Melanie Ott, MD, PhD, and Graduate Student Parinaz Fozouni comment on the COVID-19 detection test they recently developed with Nobel Laureate Jennifer Doudna, PhD, and UC Berkeley Professor Dan Fletcher, PhD, using CRISPR and smartphone technology.
Gladstone Experts COVID-19 Virology Doudna Lab Ott Lab CRISPR/Gene Editing
